Literature DB >> 21164074

Final amended safety assessment of hydroquinone as used in cosmetics.

F Alan Andersen1, Wilma F Bergfeld, Donald V Belsito, Ronald A Hill, Curtis D Klaassen, Daniel C Liebler, James G Marks, Ronald C Shank, Thomas J Slaga, Paul W Snyder.   

Abstract

Hydroquinone is an aromatic compound that functions in cosmetics as an antioxidant, fragrance, reducing agent, or polymerization inhibitor. Hydroquinone is also used as a skin bleaching agent. Safety and toxicity information indicate that hydroquinone is dermally absorbed in humans from both aqueous and alcoholic formulations and is excreted mainly as the glucuronide or sulfate conjugates. Hydroquinone is associated with altered immune function in vitro and in vivo in animals and an increased incidence of renal tubule cell tumors and leukemia in F344 rats, but the relevance to humans is uncertain. Quantitatively, however, the use of hydroquinone in cosmetics is unlikely to result in renal neoplasia through this mode of action. Thus, hydroquinone is safe at concentrations of ≤1% in hair dyes and is safe for use in nail adhesives. Hydroquinone should not be used in other leave-on cosmetics.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21164074     DOI: 10.1177/1091581810385957

Source DB:  PubMed          Journal:  Int J Toxicol        ISSN: 1091-5818            Impact factor:   2.032


  12 in total

Review 1.  Polypodium leucotomos as an Adjunct Treatment of Pigmentary Disorders.

Authors:  Mark Nestor; Vivian Bucay; Valerie Callender; Joel L Cohen; Neil Sadick; Heidi Waldorf
Journal:  J Clin Aesthet Dermatol       Date:  2014-03

2.  Comparative Study on Depigmenting Agents in Skin of Color.

Authors:  Achala Liyanage; Gayani Liyanage; Ganga Sirimanna; Nanna Schürer
Journal:  J Clin Aesthet Dermatol       Date:  2022-02

3.  Hydroquinone exposure accumulates neutral lipid by the activation of CDP-DAG pathway in Saccharomyces cerevisiae.

Authors:  Abhishek Raj; Vasanthi Nachiappan
Journal:  Toxicol Res (Camb)       Date:  2021-02-17       Impact factor: 3.524

Review 4.  Enzymatic synthesis of bioactive compounds with high potential for cosmeceutical application.

Authors:  Io Antonopoulou; Simona Varriale; Evangelos Topakas; Ulrika Rova; Paul Christakopoulos; Vincenza Faraco
Journal:  Appl Microbiol Biotechnol       Date:  2016-06-08       Impact factor: 4.813

5.  Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone.

Authors:  E Bronzina; A Clement; B Marie; K T Fook Chong; P Faure; T Passeron
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-12       Impact factor: 6.166

6.  Exogenous Ochronosis (EO): Skin lightening cream causing rare caviar-like lesion with banana-like pigments; review of literature and histological comparison with endogenous counterpart.

Authors:  Amir Qorbani; Adnan Mubasher; George Peter Sarantopoulos; Scott Nelson; Maxwell Alexander Fung
Journal:  Autops Case Rep       Date:  2020-09-02

7.  Monosubstituted Acetophenone Thiosemicarbazones as Potent Inhibitors of Tyrosinase: Synthesis, Inhibitory Studies, and Molecular Docking.

Authors:  Katarzyna Hałdys; Waldemar Goldeman; Natalia Anger-Góra; Joanna Rossowska; Rafał Latajka
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-18

8.  Hvdroquinone: Assessment of genotoxic potential in the in vivo alkaline comet assay.

Authors:  John L O'Donoghue; Carol Beevers; Annie Buard
Journal:  Toxicol Rep       Date:  2021-01-11

9.  (E)-1-(Furan-2-yl)-(substituted phenyl)prop-2-en-1-one Derivatives as Tyrosinase Inhibitors and Melanogenesis Inhibition: An In Vitro and In Silico Study.

Authors:  Hee Jin Jung; Sang Gyun Noh; Il Young Ryu; Chaeun Park; Ji Young Lee; Pusoon Chun; Hyung Ryong Moon; Hae Young Chung
Journal:  Molecules       Date:  2020-11-21       Impact factor: 4.411

Review 10.  Exogenous Ochronosis.

Authors:  Prachi A Bhattar; Vijay P Zawar; Kiran V Godse; Sharmila P Patil; Nitin J Nadkarni; Manjyot M Gautam
Journal:  Indian J Dermatol       Date:  2015 Nov-Dec       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.